(Q44345724)

English

In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile (English)

1 reference

Europe PubMed Central

2 December 2017

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

author name string

Agdeppa ED

1

1 reference

Europe PubMed Central

2 December 2017

Kepe V

2

1 reference

Europe PubMed Central

2 December 2017

Petri A

3

1 reference

Europe PubMed Central

2 December 2017

Satyamurthy N

4

1 reference

Europe PubMed Central

2 December 2017

Liu J

5

1 reference

Europe PubMed Central

2 December 2017

Huang SC

6

1 reference

Europe PubMed Central

2 December 2017

Small GW

7

1 reference

Europe PubMed Central

2 December 2017

Cole GM

8

1 reference

Europe PubMed Central

2 December 2017

Barrio JR

9

1 reference

Europe PubMed Central

2 December 2017

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

117

1 reference

Europe PubMed Central

2 December 2017

3

1 reference

Europe PubMed Central

2 December 2017

723-730

1 reference

Europe PubMed Central

2 December 2017

Absorption, distribution and toxicity of ibuprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (—)-isomer

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Binding Characteristics of Radiofluorinated 6-Dialkylamino-2-Naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for β-Amyloid Plaques in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Stereoselective disposition of ibuprofen enantiomers in human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-inflammatory drugs protect against Alzheimer disease at low doses.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Approaches to discovery and characterization of inhibitors of amyloid beta-peptide polymerization

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantifying amyloid beta-peptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel stilbenes as probes for amyloid plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo labeling of dopamine receptors: light microscopic localization at the cellular level by means of dipping autoradiography with the agonist (3H)N-n-propylnorapomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Absorption, Distribution, Metabolism, and Excretion of Naproxen in Various Laboratory Animals and Human Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural and kinetic features of amyloid beta-protein fibrillogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900907-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0306-4522(02)00907-7

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44345724&oldid=2109608884"